Sai JK, Nobukawa B, Matsumura Y, Watanabe S. Pancreatic duct lavage cytology with the cell block method for discriminating benign and malignant branch-duct type intraductal papillary mucinous neoplasms. Gastrointest Endosc.
Maruki J, Sai JK, Watanabe S. Efficacy of low-fat diet against dyspepsia associated with nonalcoholic mild pancresatic disease diagnosed using the rosemont criteria. Pancreas 2013;42;49-52.
Fujiwara N, Tateishi R, Akahane M, Taguri M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Ohtomo K, Koike K. Changes in risk of immediate adverse reactions to iodinated
contrast media by repeated administrations in patients with hepatocellular carcinoma. PLoS One. 2013;8:e76018.
Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N, Goto T, Shiina S, Yoshida H, Matsuyama Y, Omata M, Ohtomo K, Koike K. CT with hepatic arterioportography as a pretreatment examination
for hepatocellular carcinoma patients: a randomized controlled trial. Am J Gastroenterol. 2013;108:1305-13.
Tateishi R, Shiina S, Akahane M, Sato J, Kondo Y, Masuzaki R, Nakagawa H, Asaoka Y, Goto T, Otomo K, Omata M, Yoshida H, Koike K. Frequency, risk factors and survival associated with an intrasubsegmental recurrence after
radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2013;8:e59040.
Sato A, Sata M, Ikeda K, Kumada T, Izumi N, Asahina Y, Osaki Y, Chayama K, Kaneko S, Sakai A, Onji M, Hiasa Y, Omura T, Ozeki I, Yokosuka O, Shiina S, Itsubo M, Nishiguchi S, Hirano K, Ide T, Sakisaka S, Yamasaki T, Hidaka I, TanakaM,
Kim SR, Ichida T. Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. Intern Med. 2013;52:2701-6.
Shiina S. Clinical unmet need in HCC. The 23rd Conference of the Asian Pacific Association for the Study of the Liver (APASL), Singapore, Singapore, 2013/6/8
Shiina S. HCC – Asian perspective and management. The 23rd Conference of the Asian Pacific Association for the Study of the Liver (APASL), Singapore, Singapore, 2013/6/8
Shiina S. What does matter in local ablation? The 4th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE2013), Busan, Korea, 2013/7/6
Sato K, Ohki T. The overall-applicability of radical or effective hepatocellularcarcinoma treatments was unaffected by old age. AASLD 2013, Washington, USA, 2013/11/1-5
Shiina S. Prevention, identification and management of complications in radiofrequency ablation. The 3rd APASL HCC Conference, Cebu city, Philippines, 2013/11/23
Shiina S. Advances in loco-regional treatment for HCC: Ablative therapies. The 3rd APASL HCC Conference, Cebu city, Philippines, 2013/11/23
Shiina S, Rino A. Gani. RFA video ablation therapy in liver cancer. APASL-STC NASH 2013, Jakarta, Indonesia, 2013/12/1
Shiina S. Local regional therapy. APASL-STC NASH 2013, Jakarta, Indonesia, 2013/12/1